UCEF IV

  • Predictimmune

    We are delighted to announce that the University of Cambridge Enterprise Fund IV and the Parkwalk Opportunities Fund have closed an investment in Predictimmune Limited, a spinout company from the University of Cambridge. Predictimmune is developing prognostic tests… Read More

  • Focal Point Positioning

    The University of Cambridge Enterprise Fund IV has invested in Focal Point Positioning Limited, a spin-out from the University of Cambridge. Focal Point has developed software which offers highly accurate positioning of smartphones both indoors and outdoors in urban… Read More

  • Polypharmakos

    Cambridge and Kew join forces to find new antimicrobial substances in plants The Parkwalk-managed University of Cambridge Enterprise Fund IV and Cambridge Enterprise have invested £500k in Polypharmakos Limited, a spin-out from the University of Cambridge and the… Read More

  • PervasID

    PervasID  is developing a high reliability, wide area passive RFID system with the potential to provide location capability based on the EPC Class1 Gen2 standard. Spun out from research activity in the Engineering Department at the University of… Read More

  • PsyOmics

    PsyOmics  is a University of Cambridge spin-out working to improve the prevention, diagnosis and treatment of neuropsychiatric disorders. Mental illness accounts for over 15% of the disease burden in developed countries and in England alone, mental illness costs over… Read More

  • Cambridge Touch Technologies

    Cambridge Touch Technologies (CTT) is a University of Cambridge start-up developing next-gen 3D touch technology. CTT’s next generation 3D touch technology enables mobile devices to sense both the location and force of multi-touch inputs. CTT’s technology improves on… Read More

  • Cytora

    Founded in early 2013, Cytora has built an event detection technology that can detect factual, real world events in unstructured text. The technology can be scaled to cover all major event categories and be monetised across the Financial… Read More

  • Fluidic Analytics

    Fluidic Analytics is developing a line of tools for the rapid, accurate, cost-effective analysis of proteins and other biomolecular species. By combining a powerful microfluidics platform

  • DefiniGEN

    DefiniGEN provides human cells to the drug discovery sector for use in lead optimization and toxicity programmes.

Terms of Use
Cookies
Twitter
Complaints Policy
Privacy Policy

no image

© Parkwalk 2024

Parkwalk is authorised and regulated by the Financial Conduct Authority